BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang X, Zhu D, Wei L, Zhao Z, Qi X, Li Z, Sun D. OSM Enhances Angiogenesis and Improves Cardiac Function after Myocardial Infarction. Biomed Res Int 2015;2015:317905. [PMID: 26146616 DOI: 10.1155/2015/317905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Lörchner H, Adrian-Segarra JM, Waechter C, Wagner R, Góes ME, Brachmann N, Sreenivasan K, Wietelmann A, Günther S, Doll N, Braun T, Pöling J. Concomitant Activation of OSM and LIF Receptor by a Dual-Specific hlOSM Variant Confers Cardioprotection after Myocardial Infarction in Mice. Int J Mol Sci 2021;23:353. [PMID: 35008777 DOI: 10.3390/ijms23010353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ma Y. Role of Neutrophils in Cardiac Injury and Repair Following Myocardial Infarction. Cells 2021;10:1676. [PMID: 34359844 DOI: 10.3390/cells10071676] [Reference Citation Analysis]
3 Ikeda S, Sato K, Takeda M, Miki K, Aizawa K, Takada T, Fukuda K, Shiba N. Oncostatin M is a novel biomarker for coronary artery disease - A possibility as a screening tool of silent myocardial ischemia for diabetes mellitus. Int J Cardiol Heart Vasc 2021;35:100829. [PMID: 34235245 DOI: 10.1016/j.ijcha.2021.100829] [Reference Citation Analysis]
4 Du P, Guo R, Gao K, Yang S, Yao B, Cui H, Zhao M, Jia S. Identification of differentially expressed genes and the role of PDK4 in CD14+ monocytes of coronary artery disease. Biosci Rep 2021;41:BSR20204124. [PMID: 33739370 DOI: 10.1042/BSR20204124] [Reference Citation Analysis]
5 Liu B, Cheng Y, Tian J, Zhang L, Cui X. Upregulated lncRNA Pvt1 may be important for cardiac remodeling at the infarct border zone. Mol Med Rep 2020;22:2605-16. [PMID: 32945428 DOI: 10.3892/mmr.2020.11371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Keulen DV, Pouwer MG, Emilsson V, Matic LP, Pieterman EJ, Hedin U, Gudnason V, Jennings LL, Holmstrøm K, Nielsen BS, Pasterkamp G, Lindeman JHN, van Gool AJ, Sollewijn Gelpke MD, Princen HMG, Tempel D. Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans. PLoS One 2019;14:e0221477. [PMID: 31461490 DOI: 10.1371/journal.pone.0221477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
7 Adrian-Segarra JM, Schindler N, Gajawada P, Lörchner H, Braun T, Pöling J. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation. J Biol Chem 2018;293:7017-29. [PMID: 29511087 DOI: 10.1074/jbc.RA118.001920] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
8 Lan YW, Theng SM, Huang TT, Choo KB, Chen CM, Kuo HP, Chong KY. Oncostatin M-Preconditioned Mesenchymal Stem Cells Alleviate Bleomycin-Induced Pulmonary Fibrosis Through Paracrine Effects of the Hepatocyte Growth Factor. Stem Cells Transl Med 2017;6:1006-17. [PMID: 28297588 DOI: 10.5966/sctm.2016-0054] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]